» Articles » PMID: 7969172

Signal Transduction by Tumor Necrosis Factor Mediated by JNK Protein Kinases

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1994 Dec 1
PMID 7969172
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

JNK protein kinases are distantly related to mitogen-activated protein kinases (ERKs) and are activated by dual phosphorylation on Tyr and Thr. The JNK protein kinase group includes the 46-kDa isoform JNK1. Here we describe the molecular cloning of a second member of the JNK group, the 55-kDa protein kinase JNK2. The activities of both JNK isoforms are markedly increased by exposure of cells to UV radiation. Furthermore, JNK protein kinase activation is observed in cells treated with tumor necrosis factor. Although both JNK isoforms phosphorylate the NH2-terminal activation domain of the transcription factor c-Jun, the activity of JNK2 was approximately 10-fold greater than that of JNK1. This difference in c-Jun phosphorylation correlates with increased binding of c-Jun to JNK2 compared with JNK1. The distinct in vitro biochemical properties of these JNK isoforms suggest that they may have different functions in vivo. Evidence in favor of this hypothesis was obtained from the observation that JNK1, but not JNK2, complements a defect in the expression of the mitogen-activated protein kinase HOG1 in the yeast Saccharomyces cerevisiae. Together, these data indicate a role for the JNK group of protein kinases in the signal transduction pathway initiated by proinflammatory cytokines and UV radiation.

Citing Articles

Insulin signaling and pharmacology in humans and in corals.

Murthy M, Jasbi P, Lowe W, Kumar L, Olaosebikan M, Roger L PeerJ. 2024; 12:e16804.

PMID: 38313028 PMC: 10838073. DOI: 10.7717/peerj.16804.


Current Knowledge about the Peritumoral Microenvironment in Glioblastoma.

Trevisi G, Mangiola A Cancers (Basel). 2023; 15(22).

PMID: 38001721 PMC: 10670229. DOI: 10.3390/cancers15225460.


ROS-mediated SRMS activation confers platinum resistance in ovarian cancer.

Jiang Y, Song L, Lin Y, Nowialis P, Gao Q, Li T Oncogene. 2023; 42(20):1672-1684.

PMID: 37020040 PMC: 10231978. DOI: 10.1038/s41388-023-02679-6.


Coordination of MAPK and p53 dynamics in the cellular responses to DNA damage and oxidative stress.

Hanson R, Batchelor E Mol Syst Biol. 2022; 18(12):e11401.

PMID: 36472304 PMC: 9724178. DOI: 10.15252/msb.202211401.


Phosphate Toxicity and Epithelial to Mesenchymal Transition.

Lewis E, Seltun F, Razzaque M, He P Adv Exp Med Biol. 2022; 1362:73-84.

PMID: 35288874 DOI: 10.1007/978-3-030-91623-7_8.


References
1.
Abate C, Curran T . Encounters with Fos and Jun on the road to AP-1. Semin Cancer Biol. 1990; 1(1):19-26. View

2.
Tartaglia L, Goeddel D . Tumor necrosis factor receptor signaling. A dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor. J Biol Chem. 1992; 267(7):4304-7. View

3.
Iwasaki T, Uehara Y, Graves L, Rachie N, Bomsztyk K . Herbimycin A blocks IL-1-induced NF-kappa B DNA-binding activity in lymphoid cell lines. FEBS Lett. 1992; 298(2-3):240-4. DOI: 10.1016/0014-5793(92)80067-q. View

4.
Brakebusch C, Nophar Y, Kemper O, Engelmann H, Wallach D . Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor. EMBO J. 1992; 11(3):943-50. PMC: 556535. DOI: 10.1002/j.1460-2075.1992.tb05133.x. View

5.
Dressler K, Mathias S, Kolesnick R . Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science. 1992; 255(5052):1715-8. DOI: 10.1126/science.1313189. View